Corporate Strategy

Immunological Diseases

Back to list

Immunological Diseases

July 30, 2020

We focus on niche conditions with high unmet medical needs where a unique antibody approach combined with new or known targets may offer a meaningful therapeutic solution with a long-lasting impact for patients suffering from these conditions.